Latest news with #EuropeanChemicalsAgency
Yahoo
29-05-2025
- Business
- Yahoo
Metal Biocides Market Set to Hit USD 5.43 Billion by 2032, Driven by Development of Nano-Metal Biocides Creating Expansion Opportunities
Growing demand for antimicrobial coatings in healthcare and food sectors, alongside increasing regulatory focus on hygiene, propels the Metal Biocides market growth. Austin, May 29, 2025 (GLOBE NEWSWIRE) -- The Metal Biocides Market Size was valued at USD 3.96 billion in 2024 and is expected to reach USD 5.43 billion by 2032, growing at a CAGR of 4.02% over the forecast period of 2025-2032. Download PDF Sample of Metal Biocides Market @ Widening Adoption of Metal-Based Biocides Across Industries Due to Hygiene, Safety, and Innovation Demands The metal biocides market is preparing for the next level of growth as natural antimicrobials are gaining popularity due to safety and sustainability. These biocides are commonly used in paints & coatings, healthcare, and textile applications for their ability to provide antimicrobial protection and promote product durability and cleanliness. Growing concern over health, safety, and environmental regulations is driving many businesses to use more efficient and environmentally friendly biocidal products. Technological innovations are making these APIs more performant and stable, thus expanding the range of applications. Even regulatory bodies like the European Chemicals Agency (ECHA) have further promoted the use of metal biocides and gained approvals for their use in a larger range of industries across Europe. This global trend indicates a gradual move towards sustainable antimicrobials as industries prefer compliance and product integrity in the ever-more hygiene-driven markets. The US Metal Biocides Market Size was valued at USD 0.66 billion in 2023, projected to reach USD 0.96 billion by 2032, growing at a CAGR of 4.76% over the forecast period of 2024-2032. The U.S. market for biocides is expected to grow continuously on a large scale of demand in connection with healthcare, personal care, and industrial requirements. Increasing knowledge regarding the efficiency of Metal Biocides against microbial pathogens, along with increasing demand for green biocide products, is leading the market to grow. U.S. companies such as BASF have made considerable efforts to invest in new biocide formulations against the food and beverage industries to prevent contamination. Key Players: BASF SE Clariant AG Dow Chemical Company Lonza Group Ltd. Milliken Chemical Company SANITIZED AG Troy Corporation LANXESS AG DuPont Evonik Industries AG Metal Biocides Market Report Scope: Report Attributes Details Market Size in 2024 USD 3.96 Billion Market Size by 2032 USD 5.43 Billion CAGR CAGR of 4.02% From 2025 to 2032 Base Year 2024 Forecast Period 2025-2032 Historical Data 2021-2023 Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook Key Segments • By Type (Silver, Copper & Alloys, Zinc, Others)• End-Use Industry (Paints & Coatings, Medical, Textile, Pesticides, Wood Preservation, Foods & Beverages, Others) Key Drivers • Increased Application in Paints and Coatings Drive Market Growth. If You Need Any Customization on Metal Biocides Market Report, Inquire Now @ Shifting Consumer Preferences Fuel Demand for Safer Antimicrobial Solutions Consumers seek antimicrobial protection in daily-use products, boosting metal biocide demand. Demand for durable, safe goods drives biocide use in packaging and textiles. Eco-conscious buying trends push for sustainable metal biocide formulations. Transparency and safety concerns raise scrutiny of biocidal ingredients. Post-pandemic hygiene focus fuels demand for antimicrobial-coated surfaces. By Type, Silver-based Type Dominated the Metal Biocides Market in 2023 with a 42% Market Share Silver has significant antimicrobial properties, thus preventing the growth of microorganisms in different applications. As a result, it is widely used in healthcare, textile, and paint & coatings industries. The efficiency of silver and its increasing use in consumer products as a safe antimicrobial agent are what contribute to silver. Silver can be used in wound care products and medical devices, and the demand for such silver-based biocides will be especially good in wound care products because of its role in the reduction of infections. Moreover, the rising application of silver in textiles, due to its wide utilization of fabrics infused with silver, further confirms that silver is an important segment for the metal biocides market. By End-Use Industry, Paints & Coatings Dominated the Metal Biocides Market in 2023 with a 32% Market Share Metal biocides are critical to maintaining the performance and lifetime of the paint by assuring a free film from slime and biodeterioration of the coating. The continued growth in construction activities will help this segment grow as the need for antimicrobial paints increases. Favorable hygiene for building materials and high-performance, long-lasting coatings trends are expected to drive the market. This factor further drives the segment dominance as major paint manufacturers are adding metal biocides in their formulations to improve product performance. Asia Pacific dominated the Metal Biocides Market in 2023, Holding a 41.56% Market Share The demand for metal biocides in paints, textiles, and food & beverages is high in countries such as China, India, and Japan. Biocides are extensively employed throughout the Middle East region as a result of a strong Manufacturing industry, accompanied by incremental demand for Hygiene & Health. As an example, the manufacture of biocide-treated textiles, intended for hospitals and similar healthcare facilities, has become an important production activity in China. Moreover, the increasing penetration of sustainable and eco-friendly biocide solutions is also encouraging the growth of the market in this region. North America Emerged as the Fastest Growing Region in the Metal Biocides Market with A Significant Growth Rate in The Forecast Period A surge in its demand from healthcare, personal care, and paints & coatings sectors is the major factor that has been augmenting the market. In the U.S., increasing health-conscious consumers and regulatory pressure for the incorporation of antimicrobials in products have been the major aspects supporting the growth of this market. Firms such as Dow, BASF are laying substantial investment in the metal biocides formulations, especially in personal care products, as the demand for anti-microbials is substantial. Recent Developments April 2025: Arxada launched Polyboost, a multifunctional additive designed to improve pH and viscosity stability in paint formulations. This innovation supports lower preservative usage rates, aligning with industry trends toward more sustainable and efficient Full Research Report on Metal Biocides Market 2025-2032 @ Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Metal Biocides Market Segmentation, By Type 8. Metal Biocides Market Segmentation, By End Use Industry 9. Regional Analysis 10. Company Profiles 11. Use Cases and Best Practice 12. Conclusion Read Our Trending Reports: North America Biocides Market Grows Over 7% in 2023 Driven by Regulatory and Infrastructure Investments North America Leads Global Glutaraldehyde Market in 2023 with 40% Share, Driven by Healthcare Demand and Strict Infection Control Standards About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Yahoo
12-03-2025
- Health
- Yahoo
How do researchers determine how toxic a chemical is? A toxicologist explains alternatives to animal testing
A vast number of chemicals are registered for production and use around the world. But only a portion have been thoroughly evaluated for their toxicity due to time, cost, ethical concerns and regulatory limitations. To safeguard public health, researchers at organizations such as the U.S. Environmental Protection Agency, U.S. Food and Drug Administration and European Chemicals Agency evaluate the safety of the potentially hazardous chemicals people are likely to come into substantial contact with. These include volatile organic compounds such as formaldehyde, air pollutants such as nitrogen dioxide, consumer chemicals such as bisphenol A, and herbicides such as atrazine. Recently, 'forever chemicals' that persist in the environment, such as perfluorooctanesulfonic acid (PFOS) and perfluorobutane sulfonic acid (PFBS), have been the focus of human toxicity assessments. There are thousands of other chemicals used by industry that haven't been thoroughly tested. To be efficient and cost-effective, these chemicals are prioritized for targeted testing. I am a toxicologist who studies how chemicals affect human health, particularly when they cause harmful effects. Better understanding the process of determining the toxicity of chemicals could help make them safer. Historically, researchers have tested the safety and toxicity of chemicals by using biological assays, or bioassays. These tests involve exposing nonhuman animals – often rodents such as rats or mice – to a substance in controlled conditions to study its biological effects, including its potential harms. Different types of studies are designed to analyze different effects from chemicals. These include immediate effects, effects from both short-term and long-term exposure, and reproductive or developmental effects. The key premise in using bioassays in animals is that researchers can use the results to help understand the chemical's safety for people. There are, however, significant limitations in using animals to conduct these studies. First, it can be difficult to extrapolate results obtained from lab animals to humans. There are notable differences in anatomy, physiology, biochemistry and genetics between laboratory animals and people. In some cases, a chemical that is highly toxic to humans may be relatively harmless to other species. Moreover, even within a given species, there can be significant differences in how the body breaks down molecules, a process critical to determining a chemical's toxicity. It can also be costly to conduct research in animals. For example, a full battery of toxicology tests for a pesticide can cost between US$8 million and $16 million. Many of these studies take a long time to conduct, with some requiring up to two years. There are ethical concerns, too, about using animals to test the toxicity of chemicals. Many governmental agencies and commercial entities have committed to efforts that replace, reduce or refine the use of animals in research and testing. Researchers are developing a number of ways to replace animal testing in assessing chemical safety. Often called new approach methodologies, these methods aim to be both relevant to humans and scientifically clear. They also seek to be cost-effective, fast and broadly applicable. In vitro tests involve exposing biological materials such as human cells or microorganisms to different concentrations of a chemical of interest. These tests have several benefits, including easy control over experimental conditions, applicability to people, and the capacity to rapidly study many chemicals at once. The EPA's ToxCast program uses data from in vitro tests to study thousands of chemicals. There are numerous types of in vitro tests, each studying a particular quality associated with toxicity. For example, cell viability assays measure the effect of a chemical on cell survival and growth. Genotoxicity assays evaluate whether a chemical can damage genetic material. And receptor binding assays assess whether chemicals can interact with specific proteins on cells and trigger harmful effects. One type of in vitro cell model are organotypic cultures derived from actual tissues or organs. These models retain the structural and functional qualities of their original tissue. Other cell models originate from cells that self-organize in three dimensions. Examples include organoids and bioprinted tissues that can be tailored to represent specific tissues, such as the liver, skin and heart. Microphysiological systems, or organ-on-a-chip models, use miniature 3D cultures of cells from various organs – such as the liver, heart and lungs – to mimic how these organs would function in the body. With these models, researchers can assess how toxic a chemical is to multiple organs, how it is broken down in the body, and how it may cause disease. This technique offers the possibility to study the effects of chemicals on the body in a more realistic and holistic way than with organ-specific models. In chemico assays are laboratory tests or experiments that examine how chemicals interact with proteins, lipids or other cell components in a test tube or other synthetic platform. They are well suited for studies on the mechanisms underlying chemical interactions. Compared to in vitro systems, in chemico assays can be faster and more cost-effective. They may also be ethically preferred since no live cells or tissues are used. However, they may have limited biological relevance since they cannot account for how these chemicals would work in a living organism. They are also not suitable to study many aspects of chemical toxicity, such as how it affects the overall function of a cell or the body. One important aspect of chemical toxicity is figuring out what doses of a chemical trigger an unwanted side effect, or its pharmacodynamics. Another is how much of the chemical gets to its target and over what period of time, or its pharmacokinetics. When little to no experimental data is available about a chemical, researchers often rely on computer models, or in silico methods. Predicting a chemical's dose response often relies on the idea that chemicals with similar structures will have similar biological effects. Thus, if a researcher has data on chemicals similar in structure to a chemical of interest, computational models could estimate how it will affect the body. Scientists often use what are called physiologically based pharmacokinetic models to predict how a drug travels through the body. This approach mathematically divides the body into compartments – such as the liver, kidney or blood – and simulates how the chemical moves between them based on its properties and the physiology of the body. Other in silico approaches, such as virtual tissue models and quantitative adverse outcome pathways, provide additional information on how chemicals cause adverse health effects. In silico methods offer many advantages over traditional methods. They are faster and more efficient, and researchers can tailor virtual tests to more precisely simulate scenarios that would otherwise be infeasible to conduct. In silico methods are also easily replicable across labs and can help fill data gaps. However, in silico methods also have several drawbacks. These include lower accuracy with faulty models, the need for experimental data to develop models, and the lack of standards to evaluate whether in silico models are credible enough to be used to inform regulation. Policymakers are still developing regulations to assess alternatives to animal testing for chemical toxicity. These regulations vary across products and agencies. For instance, the Organisation for Economic Co-operation and Development, which comprises 38 member countries, has published nearly 100 guidelines on assessing chemical effects on human health and the environment. The International Cooperation on Alternative Test Methods was created to facilitate chemical toxicity assessment. The many partner organizations within this alliance are making efforts to ensure that alternative methods are scientifically sound, reliable and relevant to human health and environmental safety and that they can be used to replace animal testing in regulatory decision-making. With clear regulation and global collaboration, alternatives to animal testing can help advance public health, environmental safety and ethical testing practices. This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Brad Reisfeld, Colorado State University Read more: What is ethical animal research? A scientist and veterinarian explain Does this cause cancer? How scientists determine whether a chemical is carcinogenic – sometimes with controversial results Your environment affects how well your medications work − identifying exactly how could make medicine better Brad Reisfeld does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
